Consolidated Statements of Operations - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Operating expenses:
Research and development (inclusive of $9,966 and $2,403, respectively, with a related party)	$ 21,753	$ 6,950
General and administrative (inclusive of $445 and $325, respectively, with a related party)	7,579	1,954
Total operating expenses	29,332	8,904
Loss from operations	(29,332)	(8,904)
Other income (expense):
Interest income	461	4
Change in fair value of derivative liabilities	(6,393)	(15)
Other income (expense)	6	(16)
Total other income (expense), net	(5,926)	(27)
Net loss attributable to common stockholders	$ (35,258)	$ (8,931)
Net loss per share attributable to common stockholders, basic and diluted (in dollars per share)	$ (16.99)	$ (4.42)
Weighted average common shares outstanding, basic and diluted	2,075,753	2,018,623